MRI Software Announces Proposal to Take Private of Singapore-based Anacle

2025-03-05 MRI Software HaiPress

Proposal will expand MRI's presence in the Asia-Pacific real estate technology market and create future growth opportunities

SYDNEY,March 4,2025 --MRI Software,a global leader in real estate solutions and services,announces its proposal to take private of Singapore-based Anacle (8353.HK),a leading provider of digital workplace solutions,energy,facilities,property management,and real estate asset management solutions across Asia.

"This acquisition delivers immediate value to the APAC real estate market and will enable Anacle to focus on future innovations for its property and energy management systems," said John Ensign,President of MRI Software. "MRI has served the APAC market for 30 years,and this transaction will expand our established footprint in the region,bolster our solution portfolio across Asia,and build on our existing foundation of successful client outcomes."

Upon completion of the take-private transaction,Anacle will be delisted from the Hong Kong Stock Exchange,which is anticipated to reduce the burden of administrative and compliance requirements for the company. Anacle's clients will benefit from greater access to MRI's comprehensive suite of global real estate software solutions in the global markets.

"Since 2006,Anacle has been at the forefront of smart building technology in Singapore,"commented Alex Lau,CEO,Anacle. "With the support of MRI's extensive resources,services,and expertise,we anticipate that this transaction will bolster our long-term business development and drive scalability for our solutions in the APAC region."

About MRI Software

MRI Software is a global provider of real estate software applications and hosted solutions. MRI's purpose-built software helps address the unique operational challenges and financial accounting requirements facing commercial and residential property management operators,property sales and lettings agencies,real estate investment managers and facilities management companies.

MRI serves more than 45,000 organisations across 170 countries. Founded in 1971,MRI is headquartered in Cleveland,Ohio with additional offices across the United States,United Kingdom,Canada,Australia,Hong Kong,Singapore,India and South Africa,as well as an extensive partner channel. For more information,please visitmrisoftware.com/au.

Media and Investor Contact

Audrey Nicoll


Head of APAC Marketing,MRI Software


Audrey.Nicoll@mrisoftware.com

Disclaimer: This article is reproduced from other media. The purpose of reprinting is to convey more information. It does not mean that this website agrees with its views and is responsible for its authenticity, and does not bear any legal responsibility. All resources on this site are collected on the Internet. The purpose of sharing is for everyone's learning and reference only. If there is copyright or intellectual property infringement, please leave us a message.

Newest

1Cangxi County Holds 2026 New Year's Cultural Performance for the Public

Cangxi County Holds 2026 New Year's Cultural Performance for the Public

2The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

3The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

4Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange

Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange

5Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference

Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference

6Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement

Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement

©copyright 2009-2020 Singapore Info Map